Skip regulates TGF- β 1-induced extracellular matrix degrading proteases expression in human PC-3 prostate cancer cells

Prostate Cancer

Volumn 2013, Issue , 2013, Pages

  Villar, Victor ^a,b   Kocic, Jelena ^c   Santibanez, Juan F ^a,c  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MEMBRANE PROTEIN; PROTEINASE; SKI INTERACTING PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UROKINASE;

ARTICLE; CANCER CELL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; INHIBITION KINETICS; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; ZYMOGRAPHY;

EID: 84982317945     PISSN: 20903111     EISSN: 2090312X     Source Type: Journal    
DOI: 10.1155/2013/398253     Document Type: Article

References (21)

1. Padua D., Massagué J., Roles of TGFbeta in metastasis. Cell Research 2009 19 89 102
2. Wikstrom P., Stattin P., Franck-Lissbrant I., Damber J. E., Bergh A., Transforming growth factor B1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer. Prostate 1998 37 19 29 (Pubitemid 28385181)
3. Sidenius N., Blasi F., The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer and Metastasis Reviews 2003 22 2-3 205 222 2-s2.0-0038364216 10.1023/A:1023099415940 (Pubitemid 36561058)
4. Durand M. K., Bodker J. S., Christensen A., Plasminogen activator inhibitor-1 and tumor growth, invasion, and metastasis. Thrombosis and Haemostasis 2004 91 439 449
5. Deryugina E. I., Quigley J. P., Matrix metalloproteinases and tumor metastasis. Cancer and Metastasis Reviews 2006 25 1 9 34 2-s2.0-33646576169 10.1007/s10555-006-7886-9 (Pubitemid 43723979)
6. Dass K., Ahmad A., Azmi A. S., Sarkar S. H., Sarkar F. H., Evolving role of uPA/uPAR system in human cancers. Cancer Treatment Reviews 2008 34 2 122 136 2-s2.0-40649121508 10.1016/j.ctrv.2007.10.005
7. Festuccia C., Bologna M., Vicentini C., Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells. International Journal of Cancer 1996 69 386 393 (Pubitemid 26384108)
8. Van Veldhuizen P. J., Sadasivan R., Cherian R., Wyatt A., Urokinase-type plasminogen activator expression in human prostate carcinomas. American Journal of the Medical Sciences 1996 312 1 8 11 2-s2.0-0029980844 10.1097/00000441- 199607000-00002 (Pubitemid 26238890)
9. Festuccia C., Angelucci A., Gravina G. L., Villanova I., Teti A., Albini A., Bologna M., Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells. International Journal of Cancer 2000 85 407 415 (Pubitemid 30030416)
10. Konrad L., Scheiber J. A., Schwarz L., Schrader A. J., Hofmann R., TGF- β 1 and TGF- β 2 strongly enhance the secretion of plasminogen activator inhibitor-1 and matrix metalloproteinase-9 of the human prostate cancer cell line PC-3. Regulatory Peptides 2009 155 1-3 28 32 2-s2.0-66049105479 10.1016/j.regpep.2009.04.012
11. Leong G. M., Subramaniam N., Figueroa J., Flanagan J. L., Hayman M. J., Eisman J. A., Kouzmenko A. P., Ski-interacting protein interacts with Smad proteins to augment transforming growth factor-beta-dependent transcription. The Journal of Biological Chemistry 2001 276 21 18243 18248 2-s2.0-0035947674 10.1074/jbc.M010815200
12. Folk P., Půta F., Skružný M., Transcriptional coregulator SNW/SKIP: the concealed tie of dissimilar pathways. Cellular and Molecular Life Sciences 2004 61 6 629 640 2-s2.0-1842453963 10.1007/s00018-003- 3215-4 (Pubitemid 38446408)
13. Villar V., Kocic J., Bugarski D., Jovcic G., Santibanez J. F., SKIP is required for TGF- β 1-induced epithelial mesenchymal transition and migration in transformed keratinocytes. FEBS Letters 2010 584 22 4586 4592 2-s2.0-78249232622 10.1016/j.febslet.2010.10.020
14. Santibáñez J. F., Navarro A., Martínez J., Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines. Anticancer Research 1997 17 2 1199 1204 2-s2.0-1842415950 (Pubitemid 27182922)
15. Santibáñez J. F., Frontelo P., Iglesias M., Martínez J., Quintanilla M., Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes. Journal of Cellular Biochemistry 1999 74 61 73 (Pubitemid 29270028)
16. Francisco Santibáez J., Guerrero J., Quintanilla M., Fabra A., Martínez J., Transforming growth factor- β 1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes. Biochemical and Biophysical Research Communications 2002 296 2 267 273 2-s2.0-0036386902 10.1016/S0006-291X(02)00864-1
17. Bello-DeOcampo D., Tindall D. J., TGF- β /smad signaling in prostate cancer. Current Drug Targets 2003 4 3 197 207 2-s2.0-0037380050 10.2174/1389450033491118 (Pubitemid 36367618)
18. Kocic J., Bugarski D., Santibanez J. F., SMAD3 is essential for transforming growth factor- β 1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes. European Journal of Cancer 2012 48 1550 1557 2-s2.0-79960578134 10.1016/j.ejca.2011.06. 043
19. Koziczak M., Krek W., Nagamine Y., Pocket protein-independent repression of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 gene expression by E2F1. Molecular and Cellular Biology 2000 20 6 2014 2022 2-s2.0-0033993923 10.1128/MCB.20.6.2014-2022.2000 (Pubitemid 30123817)
20. Yao J. Y., Wang Y., An J., Mao C. M., Hou N., Lv Y. X., Wang Y. L., Cui F., Huang M., Yang X., Mutation analysis of the Smad3 gene in human osteoarthritis. European Journal of Human Genetics 2003 11 9 714 717 2-s2.0-0141701927 10.1038/sj.ejhg.5201034 (Pubitemid 37160995)
21. Bonniaud P., Kolb M., Galt T., Robertson J., Robbins C., Stamfli M., Lavery C., Margetts P. J., Roberts A. B., Gauldie J., Smad3 null mice develop airspace enlargement and are resistant to TGF- β -mediated pulmonary fibrosis. Journal of Immunology 2004 173 3 2099 2108 2-s2.0-3242799550 (Pubitemid 38971648)